| The use of autologous platelet gel to treat difficult‐to‐heal wounds: a pilot study L Mazzucco, D Medici, M Serra, R Panizza, G Rivara, S Orecchia, ... Transfusion 44 (7), 1013-1018, 2004 | 370 | 2004 |
| Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study ML Iacono, V Monica, L Righi, F Grosso, R Libener, S Vatrano, P Bironzo, ... Journal of thoracic oncology 10 (3), 492-499, 2015 | 191 | 2015 |
| SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma P Cacciotti, R Libener, P Betta, F Martini, C Porta, A Procopio, L Strizzi, ... Proceedings of the National Academy of Sciences 98 (21), 12032-12037, 2001 | 180 | 2001 |
| Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications L Sigalotti, S Coral, M Altomonte, L Natali, G Gaudino, P Cacciotti, ... British journal of cancer 86 (6), 979-982, 2002 | 124 | 2002 |
| SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study A Cristaudo, R Foddis, A Vivaldi, R Buselli, V Gattini, G Guglielmi, ... Cancer research 65 (8), 3049-3052, 2005 | 114 | 2005 |
| Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma M Betti, E Casalone, D Ferrante, A Aspesi, G Morleo, A Biasi, M Sculco, ... Cancer letters 405, 38-45, 2017 | 99 | 2017 |
| CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma M Betti, A Aspesi, A Biasi, E Casalone, D Ferrante, P Ogliara, LC Gironi, ... Cancer letters 378 (2), 120-130, 2016 | 89 | 2016 |
| Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high‐risk area M Betti, E Casalone, D Ferrante, A Romanelli, F Grosso, S Guarrera, ... Genes, Chromosomes and Cancer 54 (1), 51-62, 2015 | 85 | 2015 |
| The presence of simian-virus 40 sequences in mesothelioma and mesothelial cells is associated with high levels of vascular endothelial growth factor P Cacciotti, L Strizzi, G Vianale, L Iaccheri, R Libener, C Porta, M Tognon, ... American journal of respiratory cell and molecular biology 26 (2), 189-193, 2002 | 81 | 2002 |
| Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association study G Matullo, S Guarrera, M Betti, G Fiorito, D Ferrante, F Voglino, G Cadby, ... PloS one 8 (4), e61253, 2013 | 73 | 2013 |
| Molecular and histopathological characterization of the tumor immune microenvironment in advanced stage of malignant pleural mesothelioma NS Patil, L Righi, H Koeppen, W Zou, S Izzo, F Grosso, R Libener, ... Journal of Thoracic Oncology 13 (1), 124-133, 2018 | 65 | 2018 |
| Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers I Bononi, M Comar, A Puozzo, M Stendardo, P Boschetto, S Orecchia, ... Oncotarget 7 (50), 82700, 2016 | 64 | 2016 |
| Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes M Betti, A Aspesi, D Ferrante, M Sculco, L Righi, D Mirabelli, F Napoli, ... Genes, Chromosomes and Cancer 57 (11), 573-583, 2018 | 58 | 2018 |
| Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment C Riganti, MF Lingua, IC Salaroglio, C Falcomatà, L Righi, D Morena, ... Oncoimmunology 7 (3), e1398874, 2018 | 47 | 2018 |
| XRCC1 and ERCC1 variants modify malignant mesothelioma risk: A case–control study M Betti, D Ferrante, M Padoan, S Guarrera, M Giordano, A Aspesi, ... Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 708 (1 …, 2011 | 46 | 2011 |
| Aberrant E-cadherin and γ-catenin expression in malignant mesothelioma and its diagnostic and biological relevance S Orecchia, F Schillaci, M Salvio, R Libener, PG Betta Lung Cancer 45, S37-S43, 2004 | 44 | 2004 |
| Wnt/IL‐1β/IL‐8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5 V Milosevic, J Kopecka, IC Salaroglio, R Libener, F Napoli, S Izzo, ... International journal of cancer 146 (1), 192-207, 2020 | 42 | 2020 |
| A fourth case of BCR-FGFR1 positive CML-like disease with t (8; 22) translocation showing an extensive deletion on the derivative chromosome 8p. M Pini, E Gottardi, P Scaravaglio, E Giugliano, R Libener, A Baraldi, ... The Hematology Journal: the Official Journal of the European Haematology …, 2002 | 41 | 2002 |
| Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma T Villanova, I Gesmundo, V Audrito, N Vitale, F Silvagno, C Musuraca, ... Proceedings of the National Academy of Sciences 116 (6), 2226-2231, 2019 | 39 | 2019 |
| Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK‐8628 in malignant pleural mesothelioma xenografts R Vázquez, SA Licandro, L Astorgues‐Xerri, E Lettera, N Panini, ... International Journal of Cancer 140 (1), 197-207, 2017 | 36 | 2017 |
